Deans' stroke musings

Changing stroke rehab and research worldwide now.Time is Brain!Just think of all the trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group.
My back ground story is here:http://oc1dean.blogspot.com/2010/11/my-background-story_8.html

Monday, May 22, 2017

Study finds statins may not be as effective as we thought

Well DUH! Attacking a secondary problem rather that the primary problem - inflammation - is the height of stupidity. Notice that your doctor will key off the words, no history of heart disease, to keep you on statins. Followup study on stroke survivors needed, which will never occur.
https://www.yahoo.com/news/m/623ff557-4dba-335e-97c4-a227e209fb96/ss_study-finds-statins-may-not.html
Statins, the popular cholesterol-fighting medication, might not be as effective as previously believed in protecting seniors with no history of heart disease, according to a study published Monday. NYU Langone Medical Center researchers looked at 2,867 healthy older adults who were taking statins and found no evidence to suggest they were living any longer as a result, according to findings published in JAMA Internal Medicine. Statins are sold under the generic name Pravastatin and under brand names such as Lipitor, Crestor and Zocor. “Our study argues that the benefits of initiating statins in older patients, particularly those over 75, may not outweigh the risks,” said lead author Dr. Benjamin Han.

No comments:

Post a Comment